Mark Evan Goldman

Mark Evan Goldman

Photographer

About

Mark Evan Goldman, Ph.D. Was a pharmacologist at the Burnham Institute for Medical Research in La Jolla, CA. His 30+-year drug discovery background encompasses senior roles at Merck and Co. (West Point, PA), Ligand Pharmaceuticals (San Diego, CA) and Signal Pharmaceuticals (currently a division of Celgene Inc., San Diego, CA). Dr. Goldman’s experience at these institutions included leading the Merck Project Team that ultimately discovered and developed the non-nucleoside HIV reverse transcriptase inhibitor Efavirenz (Sustiva, licensed to Bristol-Myers Squibb) as well as numerous lead compounds for cancer (RAR/RXR-selective retinoids, Ligand Pharma), non-steroidal nuclear receptor agonists/antagonists (Ligand Pharma), NF-kB/AP-1 immunomodulators (Signal Pharma) and bioterror threats (PI for numerous NIH and US Department of Defense grants/contracts related to anthrax lethal factor inhibitors; Hawaii Biotech, Aiea, HI). He has served as a member of NIH counterbioterrorism study sections. He has published over 100 peer-reviewed papers and book chapters. In these roles, he also was involved in licensing drug candidates (both in-licensing and out-licensing). Dr. Goldman continues to maintain close relationships with key industry leaders at biotech companies as well as at major multi-national pharmaceutical companies. He received the Ph.D. degree in Pharmacology from The University of Texas at Austin and spent 5 years as a post-doc/senior staff fellow at the National Institutes of Health in Bethesda, MD. Some recent publications include: Goldman, M.E., Cregar, L, Nguyen, D, Simo, O, O’Malley, S and Humphreys, T. 2006 Cationic polyamines inhibit anthrax lethal factor protease. BioMedCentral Pharmacology 6 8-14. Jiao GS, Simo O, Nagata M, O’Malley S, Hemscheidt T, Cregar L, Millis SZ, Goldman ME,Tang C. 2006. Selectively guanidylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease. Bioorg. Med Chem Lettr. 16 5183-5189. Specialties: Outdoor and low light digital photography. No weddings

Country

United States

City

San Diego

Industry

Photography

Skill

Drug Discovery, Pharmacology, Biotechnology, Pharmaceutical Industry, Cancer, Small Molecules, Cross-functional Team Leadership, Retired, Drug Development, Molecular Biology, Science, Immunology, Cell Culture, Biochemistry, Clinical Development, Lifesciences, Oncology, HPLC, Assay Development, Biopharmaceuticals

Experience

Captive Moments Photography

Photographer

Captive Moments Photography

2012-7 - Present · 14 yrs 3 mos

Greater San Diego Area

Boones Pharma was acquired by Ciba-Geigy

Burnham Institute for Medical Research

Pharmacologist

Burnham Institute for Medical Research

2008-7 - 2012-7 · 4 yrs 1 mo
Hawaii Biotech, Inc.

Director

Hawaii Biotech, Inc.

LinkedIn
2000 - 2005 · 5 yrs
TorreyPines Therapeutics

Director

TorreyPines Therapeutics

LinkedIn
2000 - 2001 · 1 yr
Celgene

Director

Celgene

LinkedIn
1994 - 1999 · 5 yrs
Ligand

Director

Ligand

1992 - 1994 · 2 yrs
Merck

Scientist and Project Leader

Merck

LinkedIn
1986 - 1992 · 6 yrs

Education

The University of Texas at Austin

The University of Texas at Austin

LinkedIn

Pharmacology

1978 - 1981 · 3 yrs
The George Washington University

The George Washington University

LinkedIn

Zoology

1973 - 1976 · 3 yrs
UC San Diego

UC San Diego

LinkedIn

Mark Evan Goldman's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.